SlideShare a Scribd company logo
Diabetes Atlas:What behind numbers
Nam H. Cho, MD,PhD,CCD
Professor & Chairman of Preventive Medicine
Ajou University School of Medicine, Suwon Korea
President - Elect, International Diabetes Federation
Chairman of IDF Diabetes Atlas Committee
There are three
main types of diabetes:
Type 1 diabetes, type 2 diabetes
and gestational diabetes
Poorly managed
diabetes
leads to serious
complications
and early death
With good self-management and
health professional
support, people with diabetes can
live a long, healthy life
Diabetes: A global emergency
IDF Diabetes Atlas, 7th edition
Estimated number of people with diabetes worldwide and per region in 2015 and 2040
(20-79 years)
Diabetes around the world
IDF Diabetes Atlas, 7th edition
Men and women with diabetes
IDF Diabetes Atlas, 7th edition
≈52
Diabetes in urban and rural environments
IDF Diabetes Atlas, 7th edition
65%
74.5%
Diabetes prevalence by IDF region
IDF Diabetes Atlas, 7th edition
IDF regions by age-adjusted comparative prevalence (%) of diabetes (20-79 years), 2015
and 2040
AFR – Africa region
EUR – European region
MENA – Middle East and North African region
WP – West Pacific region
NAC – North American and Caribbean region
SACA – South and Central American region
SEA – South East Asia region
IDF Diabetes Atlas, 7th edition
Middle East and North Africa
IDF Diabetes Atlas, 7th edition
One in 7 adults have diabetes in Egypt
Diabetes (20-79 years)
2015 2040
Number of people with diabetes
(diagnosed and undiagnosed)
7.8 million
(3.8-9.0 million)
15.1 million
(7.3-17.3 million)
Raw country prevalence
14.8%
(7.2-17.1%)
17.8%
(8.6-20.4%)
Mean diabetes-related expenditure per person
with diabetes
USD 219 USD 218
Number of adults with undiagnosed diabetes
3.2 million
(1.5-3.7 million )
6.2 million
(3-7.1 million)
Percent of undiagnosed diabetes 41.20%
Number of deaths due to diabetes
78,200
(42,000-87,800)
Percent of deaths before age 60 43.60%
Top 10 countries
IDF Diabetes Atlas, 7th edition
Top ten countries/territories for number of people with diabetes (20-79 years), 2015 and 2040
One in two adults with
diabetes is
undiagnosed
Undiagnosed diabetes
IDF Diabetes Atlas, 7th edition
Undiagnosed diabetes
IDF Diabetes Atlas, 7th edition
Proportion and number of people (20-79 years)living with diabetes
who are undiagnosed, 2015
IDF region Proportion undiagnosed Number of undiagnosed
people with diabetes
Methodology
How the number was calculated?
Methodology
Methodology
IDF Diabetes Atlas, 7th edition
Number of data sources
reviewed
Countries and territories where data sources were reviewed with information on diabetes and impaired glucose
tolerance in adults (20-79 years)
Methodology
IDF Diabetes Atlas, 7th edition
Number of data sources
selected
Countries and territories for which data sources were selected for diabetes estimates in adults (20-79 years)
Methodology
IDF Diabetes Atlas, 7th edition
Countries and territories with data sources that used oral glucose tolerance tests to estimate diabetes and impaired
glucose tolerance prevalence (20-79 years)
Number of data sources
selected
Methodology
IDF Diabetes Atlas, 7th edition
Number of data sources
selected
Countries and territories with data sources less than five years old used for estimating diabetes and impaired
glucose tolerance prevalence (20-79 years)
Poorly managed
diabetes leads to
serious
complications and
early death
5.0 million people
died from diabetes
in 2015
Equivalent to one
death every six
seconds
Diabetes around the world
Diabetes accounted
for 14.5% of global
all-cause mortality
among people aged
20 to 79
46.6% of
deaths were
in people
under the
age of 60
Diabetes around the world
Africa
South East Asia
Middle East and North Africa
Western Pacific
South and Central America
North America and Caribbean
Europe
Diabetes and Economy
Estimating diabetes-related health expenditures
To estimate the health expenditures due to diabetes, the following
inputs were used:
1. IDF Diabetes Atlas estimates of diabetes prevalence
2. United Nations population estimates
3. WHO annual health expenditures
4. WHO mortality rates
5. The ratios of healthcare expenditures for people with
diabetes compared to people without diabetes
The ‘R=2’ estimates assume that health care expenditures for
people with diabetes are on average two-fold higher than people
without diabetes
12% of global
health
expenditure is
spent on
diabetes
IDF Diabetes Atlas, 7th edition
Proportion of total health expenditure estimated to be spent
on diabetes (20-79 years), R=2*, 2015
*The R=2 estimates assume that healthcare expenditures for people with diabetes are on average two-
fold higher than people without diabetes
AFR – Africa region
EUR – European region
MENA – Middle East and North African region
WP – West Pacific region
NAC – North American and Caribbean region
SACA – South and Central American region
SEA – South East Asia region
Health Expenditure on diabetes
IDF Diabetes Atlas, 7th edition
IDF Diabetes Atlas, 7th edition
An estimated
average of
1,622 USD per
person with
diabetes was
spent on
diabetes-related
health
expenditures in
2015
IDF Diabetes Atlas, 7th edition
IDF Diabetes Atlas, 7th edition
Health Expenditure on diabetes
Global health spending to treat diabetes
55%
673
802
415
642
Global estimates of
hyperglycaemia in pregnancy
Hyperglycaemia is the most common
metabolic condition in pregnant women
Can affect both mother and child with
potentially serious complications
Complications
Birth complications
post partum haemorrhage
hypertensive disorders
obstructed labour and
caesarean section
preeclampsia
infant macrosomia
Mother
An increased
lifetime risk of
developing T2DM
Child
An increased risk
of developing
T2DM later in life
GDM diagnostic criteria
Table can be found in: Linnenkamp U, Guariguata L, Beagley J, Whiting DR, Cho NH. The IDF Diabetes Atlas methodology for
estimating global prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:186–96.
No studies
1 study
2 studies
3-7 studies
>7 studies
• 108 studies from 55 countries included
Studies selection
20.9 million of women
worldwide
85.1%
7.4%
7.5%
other diabetes detected
prior to pregnancy
other diabetes detected
in pregnancy
GDM
Global burden of HIP
16.2% of live births
Global burden of HIP
0
5
10
15
20
25
30
-
2.0
4.0
6.0
8.0
AFR EUR MENA NAC SACA SEA WP
Age-adjustedprevalence,%
Absolutenumberofcases
Millions
Regional estimates of HIP in women age 20-49 years by
IDF region, 2015
Cases of hyperglycaemia in preganancy Age-adjusted regional prevalence
Age-adjusted global prevalence
South-East Asia
6.7 million (32% of all cases globally)
the highest prevalence - 26.3% (24.2% crude)
Regional figures
AFR – African region
EUR – European region
MENA – Middle East and North
African region
WP – West Pacific region
NAC – North American and
Caribbean region
SACA – South and Central
American region
SEA – South East Asia region
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
-
1.0
2.0
3.0
4.0
5.0
6.0
20-24 25-29 30-34 35-39 40-44 45-49
Prevalenceofhy[erglycaemiainpregnancy
Casesofhyperglysaemiainpregnancy/million
Woman's age in pregnancy
Absolute and relative number of hyperglycaemia cases globaly, 2015
Cases of hyperglycaemia in pregnancy Prevalence of hyperglycaemia in pregnancy
Age-dependent prevalence
50.2%
41.3%
8.5%
20-29 30-39 40-49
50.2% cases in women
aged 20-29 years
Distribution of cases of hyperglycaemia in pregnancy in
women by age groups, 2015
Age-dependent prevalence
88% cases in middle- and
low-income countries
Regional figures
LIC 9.9%
MIC 78.1%
HIC 12.0%
Distribution of cases of hyperglycaemia in
pregnancy in women aged 20-49 by World Bank
country income groups, 2015
LIC MIC HIC
LIC – Low-income countries
MIC – Middle-income countries
HIC – High-income countries
5 million people died
from diabetes
Every 2 seconds 1 new DM
IDF Diabetes Atlas, 7th edition
Conclusion
• No disease has impacted human life stronger than Diabetes
• Costs are greater than any other disease
• Threaten more life than any other disease
• Diabetes is currently unstoppable
• Early Diagnosis and management is the best remedy

More Related Content

What's hot

Chronic Disease In Malaysia
Chronic Disease In MalaysiaChronic Disease In Malaysia
Chronic Disease In Malaysia
Rashidi Ahmad
 
NHSP-IP-2
NHSP-IP-2NHSP-IP-2
C14 idf atlas 2015 eng
C14 idf atlas 2015 engC14 idf atlas 2015 eng
C14 idf atlas 2015 eng
Diabetes for all
 
Overview of Non-Communicable Diseases
Overview of Non-Communicable DiseasesOverview of Non-Communicable Diseases
Overview of Non-Communicable Diseases
Feisul Mustapha
 
Health, life expectancy and cost of living
Health, life expectancy and cost of livingHealth, life expectancy and cost of living
Health, life expectancy and cost of living
Hamzat Zaheed Adekunle
 
SLMA president address 2009
SLMA president address 2009SLMA president address 2009
SLMA president address 2009
Rezvi Sheriff
 
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocationIncreasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
Feisul Mustapha
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
Rajeev Sahai
 
Life expectancy: a comparison
Life expectancy: a comparisonLife expectancy: a comparison
Life expectancy: a comparison
Dipnarayan Thakur
 
Penyakit NCD di Malaysia
Penyakit NCD di Malaysia Penyakit NCD di Malaysia
Penyakit NCD di Malaysia
HCY 7102
 
Escalating burden of chd (1) key note address
Escalating burden of chd (1) key note addressEscalating burden of chd (1) key note address
Escalating burden of chd (1) key note address
Harivansh Chopra
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health Regulation
Sujata Mohapatra
 
Non-Communicable Diseases: Malaysia in Global Public Health
Non-Communicable Diseases: Malaysia in Global Public HealthNon-Communicable Diseases: Malaysia in Global Public Health
Non-Communicable Diseases: Malaysia in Global Public Health
Feisul Mustapha
 
Life expectancy and infant mortality
Life expectancy and infant mortalityLife expectancy and infant mortality
Life expectancy and infant mortality
SOHAILAHAMED1
 
World health day theme 2016
World health day theme 2016World health day theme 2016
World health day theme 2016
Chandra Shekar
 
Chronic diseases in developing countries
Chronic diseases in developing countriesChronic diseases in developing countries
Chronic diseases in developing countries
sivanwang
 
Test Question 3: World Life Expectancy
Test Question 3: World Life ExpectancyTest Question 3: World Life Expectancy
Test Question 3: World Life Expectancy
Gapminder
 
Financing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihmeFinancing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihme
Institute for Health Metrics and Evaluation - University of Washington
 
Determinants of mortality
Determinants of mortalityDeterminants of mortality
Determinants of mortality
Basanta Chalise
 
Jan 3 how healthy is the filipino revised december 10
Jan 3   how healthy is the filipino revised december 10Jan 3   how healthy is the filipino revised december 10
Jan 3 how healthy is the filipino revised december 10
Nash De Vivar
 

What's hot (20)

Chronic Disease In Malaysia
Chronic Disease In MalaysiaChronic Disease In Malaysia
Chronic Disease In Malaysia
 
NHSP-IP-2
NHSP-IP-2NHSP-IP-2
NHSP-IP-2
 
C14 idf atlas 2015 eng
C14 idf atlas 2015 engC14 idf atlas 2015 eng
C14 idf atlas 2015 eng
 
Overview of Non-Communicable Diseases
Overview of Non-Communicable DiseasesOverview of Non-Communicable Diseases
Overview of Non-Communicable Diseases
 
Health, life expectancy and cost of living
Health, life expectancy and cost of livingHealth, life expectancy and cost of living
Health, life expectancy and cost of living
 
SLMA president address 2009
SLMA president address 2009SLMA president address 2009
SLMA president address 2009
 
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocationIncreasing Burden of NCD in Malaysia: Challenges in resource allocation
Increasing Burden of NCD in Malaysia: Challenges in resource allocation
 
Chemotherapy
ChemotherapyChemotherapy
Chemotherapy
 
Life expectancy: a comparison
Life expectancy: a comparisonLife expectancy: a comparison
Life expectancy: a comparison
 
Penyakit NCD di Malaysia
Penyakit NCD di Malaysia Penyakit NCD di Malaysia
Penyakit NCD di Malaysia
 
Escalating burden of chd (1) key note address
Escalating burden of chd (1) key note addressEscalating burden of chd (1) key note address
Escalating burden of chd (1) key note address
 
Global burden of disease & International Health Regulation
Global burden of disease & International Health RegulationGlobal burden of disease & International Health Regulation
Global burden of disease & International Health Regulation
 
Non-Communicable Diseases: Malaysia in Global Public Health
Non-Communicable Diseases: Malaysia in Global Public HealthNon-Communicable Diseases: Malaysia in Global Public Health
Non-Communicable Diseases: Malaysia in Global Public Health
 
Life expectancy and infant mortality
Life expectancy and infant mortalityLife expectancy and infant mortality
Life expectancy and infant mortality
 
World health day theme 2016
World health day theme 2016World health day theme 2016
World health day theme 2016
 
Chronic diseases in developing countries
Chronic diseases in developing countriesChronic diseases in developing countries
Chronic diseases in developing countries
 
Test Question 3: World Life Expectancy
Test Question 3: World Life ExpectancyTest Question 3: World Life Expectancy
Test Question 3: World Life Expectancy
 
Financing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihmeFinancing global health 2011 global health council 011912_ihme
Financing global health 2011 global health council 011912_ihme
 
Determinants of mortality
Determinants of mortalityDeterminants of mortality
Determinants of mortality
 
Jan 3 how healthy is the filipino revised december 10
Jan 3   how healthy is the filipino revised december 10Jan 3   how healthy is the filipino revised december 10
Jan 3 how healthy is the filipino revised december 10
 

Similar to Ueda 2016 diabetes atlas - nam cho

Atlas 8e-poster-mena-region
Atlas 8e-poster-mena-regionAtlas 8e-poster-mena-region
Atlas 8e-poster-mena-region
Mohamed Fayek, MD, MPP
 
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
International Food Policy Research Institute (IFPRI)
 
Etiopathology of diabetes_Dr Selim
Etiopathology of diabetes_Dr SelimEtiopathology of diabetes_Dr Selim
Etiopathology of diabetes_Dr Selim
Bangabandhu Sheikh Mujib Medical University
 
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
International Food Policy Research Institute (IFPRI)
 
Health In South Africa: 20 Years After Apartheid
Health In South Africa: 20 Years After ApartheidHealth In South Africa: 20 Years After Apartheid
Health In South Africa: 20 Years After Apartheid
CUNY School of Public Health
 
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean RegionDiabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
WHO Regional Office for the Eastern Mediterranean
 
Diabetes a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes   a long-standing hyperendemic in the Eastern Mediterranean RegionDiabetes   a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes a long-standing hyperendemic in the Eastern Mediterranean Region
WHO Regional Office for the Eastern Mediterranean
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiology
Garima Gupta
 
2018 Global Nutrition Report
2018 Global Nutrition Report2018 Global Nutrition Report
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
PandurangChavan11
 
Launch of the Global Nutrition Report 2018
Launch of the Global Nutrition Report 2018Launch of the Global Nutrition Report 2018
Launch of the Global Nutrition Report 2018
Francois Stepman
 
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
International Food Policy Research Institute (IFPRI)
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Clifford Thornton
 
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Dr. Bhartendu K Srivastava (PhD)
 
Slides
SlidesSlides
Lean in Primary Care - Redesigning the Diabetes Process
Lean in Primary Care - Redesigning the Diabetes ProcessLean in Primary Care - Redesigning the Diabetes Process
Lean in Primary Care - Redesigning the Diabetes Process
Lean Enterprise Academy
 
From Unknown to UN_Charlotte Block_10.14.11
From Unknown to UN_Charlotte Block_10.14.11From Unknown to UN_Charlotte Block_10.14.11
From Unknown to UN_Charlotte Block_10.14.11
CORE Group
 
Prevention of Diabetes visual impairment and blindness
Prevention of  Diabetes visual impairment and blindness Prevention of  Diabetes visual impairment and blindness
Prevention of Diabetes visual impairment and blindness
وزارة الصحة السعودية
 
Diabetes and cardiovascular disease Case Study by diabetesasia.org
Diabetes and cardiovascular disease Case Study by diabetesasia.orgDiabetes and cardiovascular disease Case Study by diabetesasia.org
Diabetes and cardiovascular disease Case Study by diabetesasia.org
Jain hospital,Mahavir Sikshan Sansthan
 
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptxGlobal prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Prodipta Chowdhury
 

Similar to Ueda 2016 diabetes atlas - nam cho (20)

Atlas 8e-poster-mena-region
Atlas 8e-poster-mena-regionAtlas 8e-poster-mena-region
Atlas 8e-poster-mena-region
 
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
Afaf Abdel Fattah Tawfik (NNI) • 2019 IFPRI Egypt - NNC Seminar: "the 100 mil...
 
Etiopathology of diabetes_Dr Selim
Etiopathology of diabetes_Dr SelimEtiopathology of diabetes_Dr Selim
Etiopathology of diabetes_Dr Selim
 
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
Ghada Nasr (Cairo University) • 2019 IFPRI Egypt - NNC Seminar: "100 million ...
 
Health In South Africa: 20 Years After Apartheid
Health In South Africa: 20 Years After ApartheidHealth In South Africa: 20 Years After Apartheid
Health In South Africa: 20 Years After Apartheid
 
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean RegionDiabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes: a long-standing hyperendemic in the Eastern Mediterranean Region
 
Diabetes a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes   a long-standing hyperendemic in the Eastern Mediterranean RegionDiabetes   a long-standing hyperendemic in the Eastern Mediterranean Region
Diabetes a long-standing hyperendemic in the Eastern Mediterranean Region
 
Coronary heart disease - epidemiology
Coronary heart disease - epidemiologyCoronary heart disease - epidemiology
Coronary heart disease - epidemiology
 
2018 Global Nutrition Report
2018 Global Nutrition Report2018 Global Nutrition Report
2018 Global Nutrition Report
 
Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020Noncommunicable diseases worldwide 2020
Noncommunicable diseases worldwide 2020
 
Launch of the Global Nutrition Report 2018
Launch of the Global Nutrition Report 2018Launch of the Global Nutrition Report 2018
Launch of the Global Nutrition Report 2018
 
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
Ghada Nasr (Cairo University)• 2020 IFPRI Egypt - FAO Seminar: "Food Policies...
 
Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4Thornton clifford m_future_of_cardiology_09-01-2017_v4
Thornton clifford m_future_of_cardiology_09-01-2017_v4
 
Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers Cardiovascular disease (CVD) Prevention: Importance and Barriers
Cardiovascular disease (CVD) Prevention: Importance and Barriers
 
Slides
SlidesSlides
Slides
 
Lean in Primary Care - Redesigning the Diabetes Process
Lean in Primary Care - Redesigning the Diabetes ProcessLean in Primary Care - Redesigning the Diabetes Process
Lean in Primary Care - Redesigning the Diabetes Process
 
From Unknown to UN_Charlotte Block_10.14.11
From Unknown to UN_Charlotte Block_10.14.11From Unknown to UN_Charlotte Block_10.14.11
From Unknown to UN_Charlotte Block_10.14.11
 
Prevention of Diabetes visual impairment and blindness
Prevention of  Diabetes visual impairment and blindness Prevention of  Diabetes visual impairment and blindness
Prevention of Diabetes visual impairment and blindness
 
Diabetes and cardiovascular disease Case Study by diabetesasia.org
Diabetes and cardiovascular disease Case Study by diabetesasia.orgDiabetes and cardiovascular disease Case Study by diabetesasia.org
Diabetes and cardiovascular disease Case Study by diabetesasia.org
 
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptxGlobal prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
Global prevalence of prediabetes (July 2023, Diabetes Care, ADA).pptx
 

More from ueda2015

قنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقىقنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقى
ueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
ueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
ueda2015
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
ueda2015
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toony
ueda2015
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
ueda2015
 
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
Ueda2016 workshop - diabetes in the elderly  - mesbah kamelUeda2016 workshop - diabetes in the elderly  - mesbah kamel
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
ueda2015
 
Ueda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toonyUeda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toony
ueda2015
 
Ueda2016 wark shop - insulin therapy - mohamed mashahit
Ueda2016 wark shop - insulin therapy  - mohamed mashahitUeda2016 wark shop - insulin therapy  - mohamed mashahit
Ueda2016 wark shop - insulin therapy - mohamed mashahit
ueda2015
 
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
ueda2015
 
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawyUeda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
ueda2015
 
Ueda2016 tobacco and nc ds - wael safwat
Ueda2016 tobacco and nc ds -  wael safwatUeda2016 tobacco and nc ds -  wael safwat
Ueda2016 tobacco and nc ds - wael safwat
ueda2015
 
Ueda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyUeda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidy
ueda2015
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
ueda2015
 
Ueda2016 the agenda for ncd prevention and control - samer jabbour
Ueda2016 the agenda for ncd prevention and control -  samer jabbourUeda2016 the agenda for ncd prevention and control -  samer jabbour
Ueda2016 the agenda for ncd prevention and control - samer jabbour
ueda2015
 
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
ueda2015
 
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
ueda2015
 
Ueda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawishUeda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawish
ueda2015
 
Ueda2016 non pharmacological diabetes management - emad hamed
Ueda2016 non pharmacological diabetes management   - emad hamedUeda2016 non pharmacological diabetes management   - emad hamed
Ueda2016 non pharmacological diabetes management - emad hamed
ueda2015
 
Ueda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayedUeda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayed
ueda2015
 

More from ueda2015 (20)

قنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقىقنديل ام هاشم يحيى حقى
قنديل ام هاشم يحيى حقى
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Diabetesforall emad
Diabetesforall emadDiabetesforall emad
Diabetesforall emad
 
Ueda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toonyUeda2016 workshop - hypoglycemia1 -lobna el toony
Ueda2016 workshop - hypoglycemia1 -lobna el toony
 
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewaisUeda2016 new horizon in the management of dyslipidemia - diaa ewais
Ueda2016 new horizon in the management of dyslipidemia - diaa ewais
 
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
Ueda2016 workshop - diabetes in the elderly  - mesbah kamelUeda2016 workshop - diabetes in the elderly  - mesbah kamel
Ueda2016 workshop - diabetes in the elderly - mesbah kamel
 
Ueda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toonyUeda2016 woman’s health & diabetes - lobna el toony
Ueda2016 woman’s health & diabetes - lobna el toony
 
Ueda2016 wark shop - insulin therapy - mohamed mashahit
Ueda2016 wark shop - insulin therapy  - mohamed mashahitUeda2016 wark shop - insulin therapy  - mohamed mashahit
Ueda2016 wark shop - insulin therapy - mohamed mashahit
 
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...Ueda2016 wark shop - insulin pens - precise injection technique -   khaled el...
Ueda2016 wark shop - insulin pens - precise injection technique - khaled el...
 
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawyUeda2016 type 1 diabetes guidelines - hesham el hefnawy
Ueda2016 type 1 diabetes guidelines - hesham el hefnawy
 
Ueda2016 tobacco and nc ds - wael safwat
Ueda2016 tobacco and nc ds -  wael safwatUeda2016 tobacco and nc ds -  wael safwat
Ueda2016 tobacco and nc ds - wael safwat
 
Ueda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyUeda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidy
 
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
Ueda2016 the role of gut microbiota in the pathogenesis of obesity & tdm2...
 
Ueda2016 the agenda for ncd prevention and control - samer jabbour
Ueda2016 the agenda for ncd prevention and control -  samer jabbourUeda2016 the agenda for ncd prevention and control -  samer jabbour
Ueda2016 the agenda for ncd prevention and control - samer jabbour
 
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...Ueda2016 recommendations for management of diabetes during ramadan - update 2...
Ueda2016 recommendations for management of diabetes during ramadan - update 2...
 
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
Ueda2016 prevention of diabetes,the role of patients’ associations -mominaat ...
 
Ueda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawishUeda2016 pitfalls in df - hanan gawish
Ueda2016 pitfalls in df - hanan gawish
 
Ueda2016 non pharmacological diabetes management - emad hamed
Ueda2016 non pharmacological diabetes management   - emad hamedUeda2016 non pharmacological diabetes management   - emad hamed
Ueda2016 non pharmacological diabetes management - emad hamed
 
Ueda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayedUeda2016 nc ds alliances - adel el sayed
Ueda2016 nc ds alliances - adel el sayed
 

Recently uploaded

PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
MwambaChikonde1
 
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing studentsHelminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
RAJU B N
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
Dr. Nikhilkumar Sakle
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Dr. Nikhilkumar Sakle
 
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
Donc Test
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
Dr. Dhwani kawedia
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
MuskanShingari
 
Microbiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the MicroscopeMicrobiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the Microscope
ThaShee2
 
Public Health Lecture 4 Social Sciences and Public Health
Public Health Lecture 4 Social Sciences and Public HealthPublic Health Lecture 4 Social Sciences and Public Health
Public Health Lecture 4 Social Sciences and Public Health
phuakl
 
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Jim Jacob Roy
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
Bhavyakelawadiya
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
Dr. Sumit KUMAR
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
NX Healthcare
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
Bhavyakelawadiya
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Mobile Problem
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
Aswan University Hospital
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
Dr Nitin Tyagi
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
Torstein Dalen-Lorentsen
 

Recently uploaded (20)

PARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptxPARASITIC INFECTIONS IN CHILDREN peads.pptx
PARASITIC INFECTIONS IN CHILDREN peads.pptx
 
Helminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing studentsHelminthiasis or Worm infestation in Children for Nursing students
Helminthiasis or Worm infestation in Children for Nursing students
 
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdf
 
Pharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and AntagonistPharmacology of 5-hydroxytryptamine and Antagonist
Pharmacology of 5-hydroxytryptamine and Antagonist
 
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and LeukotrienesPharmacology of Prostaglandins, Thromboxanes and Leukotrienes
Pharmacology of Prostaglandins, Thromboxanes and Leukotrienes
 
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
TEST BANK For Brunner and Suddarth's Textbook of Medical-Surgical Nursing, 14...
 
biomechanics of running. Dr.dhwani.pptx
biomechanics of running.   Dr.dhwani.pptxbiomechanics of running.   Dr.dhwani.pptx
biomechanics of running. Dr.dhwani.pptx
 
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
Computer in pharmaceutical research and development-Mpharm(Pharmaceutics)
 
Microbiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the MicroscopeMicrobiology & Parasitology Exercises Parts of the Microscope
Microbiology & Parasitology Exercises Parts of the Microscope
 
Public Health Lecture 4 Social Sciences and Public Health
Public Health Lecture 4 Social Sciences and Public HealthPublic Health Lecture 4 Social Sciences and Public Health
Public Health Lecture 4 Social Sciences and Public Health
 
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
Spontaneous Bacterial Peritonitis - Pathogenesis , Clinical Features & Manage...
 
RESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiyaRESPIRATORY DISEASES by bhavya kelavadiya
RESPIRATORY DISEASES by bhavya kelavadiya
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
Breast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapyBreast cancer: Post menopausal endocrine therapy
Breast cancer: Post menopausal endocrine therapy
 
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International TravelersTravel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
 
Nutritional deficiency disorder in Child
Nutritional deficiency disorder in ChildNutritional deficiency disorder in Child
Nutritional deficiency disorder in Child
 
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl MumbaiCall Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
Call Girls In Mumbai +91-7426014248 High Profile Call Girl Mumbai
 
All about shoulder Joint ..
All about shoulder Joint .. All about shoulder Joint ..
All about shoulder Joint ..
 
Patellar Instability: Diagnosis Management
Patellar Instability: Diagnosis  ManagementPatellar Instability: Diagnosis  Management
Patellar Instability: Diagnosis Management
 
Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024Physical demands in sports - WCSPT Oslo 2024
Physical demands in sports - WCSPT Oslo 2024
 

Ueda 2016 diabetes atlas - nam cho

  • 1. Diabetes Atlas:What behind numbers Nam H. Cho, MD,PhD,CCD Professor & Chairman of Preventive Medicine Ajou University School of Medicine, Suwon Korea President - Elect, International Diabetes Federation Chairman of IDF Diabetes Atlas Committee
  • 2. There are three main types of diabetes: Type 1 diabetes, type 2 diabetes and gestational diabetes Poorly managed diabetes leads to serious complications and early death With good self-management and health professional support, people with diabetes can live a long, healthy life
  • 3. Diabetes: A global emergency IDF Diabetes Atlas, 7th edition Estimated number of people with diabetes worldwide and per region in 2015 and 2040 (20-79 years)
  • 4. Diabetes around the world IDF Diabetes Atlas, 7th edition
  • 5. Men and women with diabetes IDF Diabetes Atlas, 7th edition ≈52
  • 6. Diabetes in urban and rural environments IDF Diabetes Atlas, 7th edition 65% 74.5%
  • 7. Diabetes prevalence by IDF region IDF Diabetes Atlas, 7th edition IDF regions by age-adjusted comparative prevalence (%) of diabetes (20-79 years), 2015 and 2040 AFR – Africa region EUR – European region MENA – Middle East and North African region WP – West Pacific region NAC – North American and Caribbean region SACA – South and Central American region SEA – South East Asia region
  • 8. IDF Diabetes Atlas, 7th edition Middle East and North Africa
  • 9. IDF Diabetes Atlas, 7th edition One in 7 adults have diabetes in Egypt Diabetes (20-79 years) 2015 2040 Number of people with diabetes (diagnosed and undiagnosed) 7.8 million (3.8-9.0 million) 15.1 million (7.3-17.3 million) Raw country prevalence 14.8% (7.2-17.1%) 17.8% (8.6-20.4%) Mean diabetes-related expenditure per person with diabetes USD 219 USD 218 Number of adults with undiagnosed diabetes 3.2 million (1.5-3.7 million ) 6.2 million (3-7.1 million) Percent of undiagnosed diabetes 41.20% Number of deaths due to diabetes 78,200 (42,000-87,800) Percent of deaths before age 60 43.60%
  • 10. Top 10 countries IDF Diabetes Atlas, 7th edition Top ten countries/territories for number of people with diabetes (20-79 years), 2015 and 2040
  • 11. One in two adults with diabetes is undiagnosed
  • 12. Undiagnosed diabetes IDF Diabetes Atlas, 7th edition
  • 13. Undiagnosed diabetes IDF Diabetes Atlas, 7th edition Proportion and number of people (20-79 years)living with diabetes who are undiagnosed, 2015 IDF region Proportion undiagnosed Number of undiagnosed people with diabetes
  • 14. Methodology How the number was calculated?
  • 16. Methodology IDF Diabetes Atlas, 7th edition Number of data sources reviewed Countries and territories where data sources were reviewed with information on diabetes and impaired glucose tolerance in adults (20-79 years)
  • 17. Methodology IDF Diabetes Atlas, 7th edition Number of data sources selected Countries and territories for which data sources were selected for diabetes estimates in adults (20-79 years)
  • 18. Methodology IDF Diabetes Atlas, 7th edition Countries and territories with data sources that used oral glucose tolerance tests to estimate diabetes and impaired glucose tolerance prevalence (20-79 years) Number of data sources selected
  • 19. Methodology IDF Diabetes Atlas, 7th edition Number of data sources selected Countries and territories with data sources less than five years old used for estimating diabetes and impaired glucose tolerance prevalence (20-79 years)
  • 20. Poorly managed diabetes leads to serious complications and early death
  • 21. 5.0 million people died from diabetes in 2015 Equivalent to one death every six seconds
  • 23. Diabetes accounted for 14.5% of global all-cause mortality among people aged 20 to 79 46.6% of deaths were in people under the age of 60
  • 27. Middle East and North Africa
  • 29. South and Central America
  • 30. North America and Caribbean
  • 33. Estimating diabetes-related health expenditures To estimate the health expenditures due to diabetes, the following inputs were used: 1. IDF Diabetes Atlas estimates of diabetes prevalence 2. United Nations population estimates 3. WHO annual health expenditures 4. WHO mortality rates 5. The ratios of healthcare expenditures for people with diabetes compared to people without diabetes The ‘R=2’ estimates assume that health care expenditures for people with diabetes are on average two-fold higher than people without diabetes
  • 34. 12% of global health expenditure is spent on diabetes
  • 35. IDF Diabetes Atlas, 7th edition Proportion of total health expenditure estimated to be spent on diabetes (20-79 years), R=2*, 2015 *The R=2 estimates assume that healthcare expenditures for people with diabetes are on average two- fold higher than people without diabetes AFR – Africa region EUR – European region MENA – Middle East and North African region WP – West Pacific region NAC – North American and Caribbean region SACA – South and Central American region SEA – South East Asia region Health Expenditure on diabetes
  • 36. IDF Diabetes Atlas, 7th edition
  • 37. IDF Diabetes Atlas, 7th edition
  • 38. An estimated average of 1,622 USD per person with diabetes was spent on diabetes-related health expenditures in 2015
  • 39. IDF Diabetes Atlas, 7th edition
  • 40. IDF Diabetes Atlas, 7th edition Health Expenditure on diabetes Global health spending to treat diabetes 55% 673 802 415 642
  • 42. Hyperglycaemia is the most common metabolic condition in pregnant women Can affect both mother and child with potentially serious complications
  • 43. Complications Birth complications post partum haemorrhage hypertensive disorders obstructed labour and caesarean section preeclampsia infant macrosomia Mother An increased lifetime risk of developing T2DM Child An increased risk of developing T2DM later in life
  • 44. GDM diagnostic criteria Table can be found in: Linnenkamp U, Guariguata L, Beagley J, Whiting DR, Cho NH. The IDF Diabetes Atlas methodology for estimating global prevalence of hyperglycaemia in pregnancy. Diabetes Res Clin Pract 2014;103:186–96.
  • 45. No studies 1 study 2 studies 3-7 studies >7 studies • 108 studies from 55 countries included Studies selection
  • 46. 20.9 million of women worldwide 85.1% 7.4% 7.5% other diabetes detected prior to pregnancy other diabetes detected in pregnancy GDM Global burden of HIP
  • 47. 16.2% of live births Global burden of HIP
  • 48. 0 5 10 15 20 25 30 - 2.0 4.0 6.0 8.0 AFR EUR MENA NAC SACA SEA WP Age-adjustedprevalence,% Absolutenumberofcases Millions Regional estimates of HIP in women age 20-49 years by IDF region, 2015 Cases of hyperglycaemia in preganancy Age-adjusted regional prevalence Age-adjusted global prevalence South-East Asia 6.7 million (32% of all cases globally) the highest prevalence - 26.3% (24.2% crude) Regional figures AFR – African region EUR – European region MENA – Middle East and North African region WP – West Pacific region NAC – North American and Caribbean region SACA – South and Central American region SEA – South East Asia region
  • 49. 0.0% 10.0% 20.0% 30.0% 40.0% 50.0% - 1.0 2.0 3.0 4.0 5.0 6.0 20-24 25-29 30-34 35-39 40-44 45-49 Prevalenceofhy[erglycaemiainpregnancy Casesofhyperglysaemiainpregnancy/million Woman's age in pregnancy Absolute and relative number of hyperglycaemia cases globaly, 2015 Cases of hyperglycaemia in pregnancy Prevalence of hyperglycaemia in pregnancy Age-dependent prevalence
  • 50. 50.2% 41.3% 8.5% 20-29 30-39 40-49 50.2% cases in women aged 20-29 years Distribution of cases of hyperglycaemia in pregnancy in women by age groups, 2015 Age-dependent prevalence
  • 51. 88% cases in middle- and low-income countries Regional figures LIC 9.9% MIC 78.1% HIC 12.0% Distribution of cases of hyperglycaemia in pregnancy in women aged 20-49 by World Bank country income groups, 2015 LIC MIC HIC LIC – Low-income countries MIC – Middle-income countries HIC – High-income countries
  • 52. 5 million people died from diabetes Every 2 seconds 1 new DM
  • 53. IDF Diabetes Atlas, 7th edition Conclusion • No disease has impacted human life stronger than Diabetes • Costs are greater than any other disease • Threaten more life than any other disease • Diabetes is currently unstoppable • Early Diagnosis and management is the best remedy